Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1036-1042
Published online before print February 23, 2006, doi: 10.1161/01.ATV.0000215179.76144.39
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/5/1036    most recent
01.ATV.0000215179.76144.39v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niwano, K.
Right arrow Articles by Kurabayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niwano, K.
Right arrow Articles by Kurabayashi, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1036.)
© 2006 American Heart Association, Inc.


Vascular Biology

Competitive Binding of CREB and ATF2 to cAMP/ATF Responsive Element Regulates eNOS Gene Expression in Endothelial Cells

Kazuo Niwano; Masashi Arai; Norimichi Koitabashi; Shiro Hara; Atai Watanabe; Kenichi Sekiguchi; Toru Tanaka; Tatsuya Iso; Masahiko Kurabayashi

From the Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Japan.

Correspondence to Masahiko Kurabayashi, MD, PhD, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan. E-mail mkuraba{at}med.gunma-u.ac.jp

Objective— Expression of endothelial nitric oxide synthase (eNOS) is a critical determinant for vascular homeostasis. We examined the effects of Beraprost sodium (BPS), a stable analogue of prostacyclin, on the eNOS gene expression in the presence of inflammatory cytokine interleukin (IL)-1ß in cultured endothelial cells.

Method and Results— Exposure of human and bovine endothelial cells to IL-1ß decreased eNOS expression. Western blot analysis using phospho-specific antibodies showed that IL-1ß stimulated p38 MAP kinase and phosphorylated ATF2. BPS inhibited these effects via protein kinase A (PKA)/cAMP-responsive element binding protein (CREB) activation. Transfection assays using site-specific mutation constructs showed that CRE/ATF elements located at –733 and –603 within the human eNOS promoter are necessary for full IL-1ß responsiveness. BPS attenuated the IL-1ß–mediated decrease in eNOS promoter activity and the expression of eNOS gene through PKA pathway. Electrophoretic gel mobility shift assays showed that IL-1ß increased the binding of phosphorylated ATF2 to CRE/ATF. On treatment with BPS, phosphorylated CREB predominantly bound to CRE/ATF.

Conclusions— These results indicate that IL-1ß and BPS antagonistically regulates the eNOS expression through the activation of p38 and PKA, respectively. Furthermore, the ability to bind both CREB and ATF2 implicates the CRE/ATF sequence as a potential target for multiple signaling pathways in the regulation of the eNOS gene transcription.

The expression level of the eNOS gene is a critical determinant of endothelial integrity. Beraprost sodium (BPS) inhibited the downregulation of eNOS gene expression by IL-1ß through competitive binding of ATF2 and CREB to ATF/CREB sequences. The data indicate a potential role of ATF/CREB family of transcription factors in atherosclerosis.


Key Words: cAMP • cytokine • endothelium • prostacyclin • transcription factor




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Strassheim, S. R. Riddle, D. L. Burke, M. W. Geraci, and K. R. Stenmark
Prostacyclin Inhibits IFN-{gamma}-Stimulated Cytokine Expression by Reduced Recruitment of CBP/p300 to STAT1 in a SOCS-1-Independent Manner
J. Immunol., December 1, 2009; 183(11): 6981 - 6988.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Deng, H. Liu, J. Huang, L. Cheng, E. T. Keller, S. J. Parsons, and C.-D. Hu
Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression
Cancer Res., December 1, 2008; 68(23): 9663 - 9670.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Chinnappan, X. Qu, D. Xiao, A. Ratnasari, and H. C. Weber
Human gastrin-releasing peptide receptor gene regulation requires transcription factor binding at two distinct CRE sites
Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G153 - G162.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Colmone, S. Li, and C.-R. Wang
Activating Transcription Factor/cAMP Response Element Binding Protein Family Member Regulated Transcription of CD1A
J. Immunol., November 15, 2006; 177(10): 7024 - 7032.
[Abstract] [Full Text] [PDF]